Invited Speakers

Lola Eniola-Adefeso

Associate Dean for Graduate & Professional Education, Michigan Engineering

Vennema Endowed Professor of Engineering, University Diversity and Social Transformation Professor of Chemical Engineering, Biomedical Engineering, and Macromolecular Science & Engineering

University of Michigan

NCRC, 2800 Plymouth Road, Ann Arbor, MI 48109

U.S.A.

Group Website: https://cadd.engin.umich.edu/

Lola Eniola-Adefeso received a doctoral degree (2004) in Chemical and Biomolecular Engineering at the University of Pennsylvania. She was a postdoctoral associate in Pediatrics/Leukocyte Biology at Baylor College of Medicine. Dr. Eniola-Adefeso joined the University of Michigan in 2006 and is currently the Associate Dean for Graduate and Professional Education for Michigan Engineering. Her pioneering research at the interface of cellular biomechanics, biomolecular surface, and immunology has contributed significantly to advancing immunoengineering and developing novel polymeric particle therapies for acute inflammatory diseases and has received several awards and honors for her groundbreaking work in the field, including the Biomedical Engineering Society (BMES) Mid-Career Award for Scholarship and Practice of Biomedical Engineering and the CMBE Chris Jacob Excellence in Leadership Award. She is a Fellow of BMES, the American Institute for Medical and Biological Engineering (AIMBE), the American Heart Association (AHA), the American Institute of Chemical Engineering (AIChE), the Controlled Release Society (CRS), and a Senior Member of the National Academy of Inventors. She is the current national president of AIMBE. Her research is currently funded by multiple grants from the NIH, AHA, and NSF.

Representative Publications

[1]    Banka, A.L., M.V. Guevara, R. Adili, E.R. Brannon, N.Q. Nguyen, S. Song, G. Cady, D.J. Pinsky, K.E Uhrich, R. Adili M. Holinstat, and O. Eniola-Adefeso. (2023) "Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation." Nat Comm 14 (1), 2462.

[2]    Brannon, E.R., M.V. Guevara, N.J. Pacifici, J.K. Lee, J.S. Lewis, and O Eniola-Adefeso. (2022) “Polymeric particle-based approaches to targeting and modulating acute inflammation.” Nat Rev Mater. 7(10), 796-813.

[3]    Brannon E.R., Kelley, W.J., A.L. Banka, M. Newstead, K. Uhrich, C. O’Connor, T.J. Standiford, and O. Eniola-Adefeso. (2022). “Salicylate-based particle decoys therapeutically treat acute respiratory distress syndrome.” Advanced Healthcare Material. Apr;11(7): e2101534. doi: 10.1002/adhm.202101534.

[4]    Fish, M., A.L. Banka, M. Braunreuther, C.A. Fromen, W.J. Kelley, J.K.H. Lee, R. Adili, M. Holinstat, and O. Eniola-Adefeso (2021) “Deformable Microparticles for Shuttling Nanoparticles to the Vascular Wall.” Science Advances. 7(17): eabe0143.

[5]    Safari, H., Kelley, W., and O. Eniola-Adefeso. (2020) “Neutrophils preferentially eat elongated particles – opportunity for selective targeting in acute inflammatory diseases.” Science Advances. 6 (24), eaba1474.